Feds appraise the value of nuclear medicine research
The government plans to spend nearly $800,000 to determine the strategic importance of nuclear medicine research, according to National Institutes of Health chief Dr. Elias Zerhouni. Society of Nuclear Medicine president Dr. Peter Conti is encouraged about the initiative.
The government plans to spend nearly $800,000 to determine the strategic importance of nuclear medicine research, according to National Institutes of Health chief Dr. Elias Zerhouni. Society of Nuclear Medicine president Dr. Peter Conti is encouraged about the initiative.
"At least it shows that somebody cares about nuclear medicine research and wants to study it. That's a lot better than cuts made because it is thought to have no value," Conti said.
The Department of Energy and the NIH will spend 13 months investigating topics such as radiopharmaceutical development for diagnosis and therapy, software and hardware development for more precise radiotracer localization, hurdles facing the incorporation of new radiopharmaceutical compounds, and strategies to overcome probable shortages of isotopes and qualified researchers.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
